Rooted in China and looking to the world. To build ultra-large-scale, first-class manufacturing capacity for global market expansion, Zencore has completed a large-scale commercial manufacturing base in Lingang (Linjia Base): its two drug substance production lines are equipped with 3×2,000 L single-use bioreactors and 3×5,000 L stainless-steel bioreactors respectively, reaching the 20,000 L+ ultra-large-scale tier and now in operation to serve Phase III clinical and large-scale commercial manufacturing. An even larger 6×15,000 L production line is also in preparation.
In view of diverse future client needs and Zencore's vigorous global business expansion, Zencore'sThe first commercial manufacturing basewill be built into:

Zencore has invested significantly in commercial manufacturing equipment: the 2,000 L line uses a hybrid single-use and stainless-steel configuration, while the 5,000 L line uses an all-stainless-steel system. This balances production flexibility, reduces process failure risk and lowers manual-operation and supply-chain maintenance risks that could affect production quality and timelines.
A hybrid production line combining single-use bioreactors with downstream stainless-steel systems
Fully stainless-steel upstream and downstream facilities, with single-use bioreactors
20,000 L+ dual single-use and stainless-steel production lines, transparent manufacturing and a global supply chain - joining you on the path to product launch.
Inquire about commercial manufacturing